N,N-Sulfonylbisurea (BioDeep_00000843052)

   


代谢物信息卡片


N,N-Sulfonylbisurea

化学式: C2H6N4O4S (182.0109756)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C(=O)(N)NS(=O)(=O)NC(=O)N
InChI: InChI=1S/C2H6N4O4S/c3-1(7)5-11(9,10)6-2(4)8/h(H3,3,5,7)(H3,4,6,8)

描述信息

同义名列表

1 个代谢物同义名

N,N-Sulfonylbisurea



数据库引用编号

3 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Ryan Matsuda, Jeanethe Anguizola, K S Joseph, David S Hage. Analysis of drug interactions with modified proteins by high-performance affinity chromatography: binding of glibenclamide to normal and glycated human serum albumin. Journal of chromatography. A. 2012 Nov; 1265(?):114-22. doi: 10.1016/j.chroma.2012.09.091. [PMID: 23092871]
  • Miguel Glatstein, Dennis Scolnik, Yedidia Bentur. Octreotide for the treatment of sulfonylurea poisoning. Clinical toxicology (Philadelphia, Pa.). 2012 Nov; 50(9):795-804. doi: 10.3109/15563650.2012.734626. [PMID: 23046209]
  • R Pencek, A Blickensderfer, Y Li, S C Brunell, S Chen. Exenatide once weekly for the treatment of type 2 diabetes: effectiveness and tolerability in patient subpopulations. International journal of clinical practice. 2012 Nov; 66(11):1021-32. doi: 10.1111/j.1742-1241.2012.03006.x. [PMID: 22925173]
  • Yuhya Wakasa, Kenjirou Ozawa, Fumio Takaiwa. Agrobacterium-mediated co-transformation of rice using two selectable marker genes derived from rice genome components. Plant cell reports. 2012 Nov; 31(11):2075-84. doi: 10.1007/s00299-012-1318-9. [PMID: 22843026]
  • Mi-Seon Shin, Jee Hee Yu, Chang Hee Jung, Jenie Yoonoo Hwang, Woo Je Lee, Min-Seon Kim, Joong-Yeol Park. The duration of sulfonylurea treatment is associated with β-cell dysfunction in patients with type 2 diabetes mellitus. Diabetes technology & therapeutics. 2012 Nov; 14(11):1033-42. doi: 10.1089/dia.2012.0144. [PMID: 22958196]
  • Meilian Liu, Feng Liu. Up- and down-regulation of adiponectin expression and multimerization: mechanisms and therapeutic implication. Biochimie. 2012 Oct; 94(10):2126-30. doi: 10.1016/j.biochi.2012.01.008. [PMID: 22342903]
  • Elvira O Gosmanova, Robert B Canada, Jim Wan, Therese A Mangold, Barry M Wall. Different antidiabetic regimens and the development of renal dysfunction in US Veterans with type 2 diabetes mellitus. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 2012 Oct; 60(7):1009-14. doi: 10.2310/jim.0b013e3182621dbf. [PMID: 22801248]
  • Na Lu, Minxia Zhan, Cong Gao, Guanzhong Wu, Huibing Zhang. I4, a new synthetic sulfonylurea compound, inhibits the action of TXA2 in vivo and in vitro on platelets and aorta vascular smooth muscle. Thrombosis research. 2012 Oct; 130(4):e209-15. doi: 10.1016/j.thromres.2012.07.022. [PMID: 22909828]
  • Y Seino, K W Min, E Niemoeller, A Takami. Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia). Diabetes, obesity & metabolism. 2012 Oct; 14(10):910-7. doi: 10.1111/j.1463-1326.2012.01618.x. [PMID: 22564709]
  • Matthias Blüher, Ira Kurz, Simone Dannenmaier, Markus Dworak. Efficacy and safety of vildagliptin in clinical practice-results of the PROVIL-study. World journal of diabetes. 2012 Sep; 3(9):161-9. doi: 10.4239/wjd.v3.i9.161. [PMID: 23125906]
  • X H Lu, Z H Kang, B Tao, Y N Wang, J G Dong, J L Zhang. Degradation of nicosulfuron by Bacillus subtilis YB1 and Aspergillus niger YF1. Prikladnaia biokhimiia i mikrobiologiia. 2012 Sep; 48(5):510-5. doi: . [PMID: 23101388]
  • Abbas Ahmadi, Mohsen Khalili, Seyedsobhan Seyedhoseyni, Ehsan Maadi Roudsari, Babak Nahri-Niknafs. Synthesis, antidiabetic and hypolipidemic activities of new diethylamine and triethoxysilyl derivatives of tolbutamide on rats. Medicinal chemistry (Shariqah (United Arab Emirates)). 2012 Sep; 8(5):964-9. doi: 10.2174/157340612802084261. [PMID: 22741777]
  • Seyyed Morteza Taghavi, Seyyede Sedighe Fatemi, Hale Rokni. Cabergoline effect on blood sugar in type 2 diabetic patients with oral agent failure. The Medical journal of Malaysia. 2012 Aug; 67(4):390-2. doi: NULL. [PMID: 23082447]
  • Yoshifuru Tamura, Katsuyuki Tanabe, Wataru Kitagawa, Shunya Uchida, George F Schreiner, Richard J Johnson, Takahiko Nakagawa. Nicorandil, a K(atp) channel opener, alleviates chronic renal injury by targeting podocytes and macrophages. American journal of physiology. Renal physiology. 2012 Aug; 303(3):F339-49. doi: 10.1152/ajprenal.00158.2012. [PMID: 22622455]
  • Nora Nikolac, Ana-Maria Simundic, Andrea Saracevic, Darko Katalinic. ABCC8 polymorphisms are associated with triglyceride concentration in type 2 diabetics on sulfonylurea therapy. Genetic testing and molecular biomarkers. 2012 Aug; 16(8):924-30. doi: 10.1089/gtmb.2011.0337. [PMID: 22533711]
  • K Hoa Nguyen, T Nhan Ta, T Hong Minh Pham, Q Tien Nguyen, H Dien Pham, Suresh Mishra, B L Grégoire Nyomba. Nuciferine stimulates insulin secretion from beta cells-an in vitro comparison with glibenclamide. Journal of ethnopharmacology. 2012 Jul; 142(2):488-95. doi: 10.1016/j.jep.2012.05.024. [PMID: 22633982]
  • Serge A Jabbour, Jean M Whaley, Mark Tirmenstein, Simon M Poucher, Timothy P Reilly, David W Boulton, Joanne Saye, James F List, Shamik Parikh. Targeting renal glucose reabsorption for the treatment of type 2 diabetes mellitus using the SGLT2 inhibitor dapagliflozin. Postgraduate medicine. 2012 Jul; 124(4):62-73. doi: 10.3810/pgm.2012.07.2569. [PMID: 22913895]
  • Richard Pencek, Amy Blickensderfer, Yan Li, Steven C Brunell, Pamela W Anderson. Exenatide twice daily: analysis of effectiveness and safety data stratified by age, sex, race, duration of diabetes, and body mass index. Postgraduate medicine. 2012 Jul; 124(4):21-32. doi: 10.3810/pgm.2012.07.2567. [PMID: 22913891]
  • Richard Pencek, Steven C Brunell, Yan Li, Byron J Hoogwerf, James Malone. Exenatide once weekly for the treatment of type 2 diabetes mellitus: clinical results in subgroups of patients using different concomitant medications. Postgraduate medicine. 2012 Jul; 124(4):33-40. doi: 10.3810/pgm.2012.07.2568. [PMID: 22913892]
  • Ritesh Agrawal, Pratima Jain, S N Dikshit. Linagliptin: a novel methylxanthin based approved dipeptidyl peptidase-4 inhibitor. Current drug targets. 2012 Jun; 13(7):970-83. doi: 10.2174/138945012800675731. [PMID: 22420306]
  • Walid Saliba, Goldstein Lee, Naief Habashi, Mazen Elias. [Hepcidin and diabetic anemia: is there an association?]. Harefuah. 2012 May; 151(5):257-60, 320. doi: NULL. [PMID: 22844726]
  • G Schernthaner, A H Barnett, A Emser, S Patel, J Troost, H-J Woerle, M von Eynatten. Safety and tolerability of linagliptin: a pooled analysis of data from randomized controlled trials in 3572 patients with type 2 diabetes mellitus. Diabetes, obesity & metabolism. 2012 May; 14(5):470-8. doi: 10.1111/j.1463-1326.2012.01565.x. [PMID: 22268497]
  • Mechelle J Owen, Danica E Goggin, Stephen B Powles. Identification of resistance to either paraquat or ALS-inhibiting herbicides in two Western Australian Hordeum leporinum biotypes. Pest management science. 2012 May; 68(5):757-63. doi: 10.1002/ps.2323. [PMID: 22290852]
  • H-W M Breuer, P Ptak. [Hypoglycemia - frequency, causes, induced costs]. Deutsche medizinische Wochenschrift (1946). 2012 May; 137(19):988-92. doi: 10.1055/s-0031-1299014. [PMID: 22549254]
  • José Fenoll, Pilar Hellín, Pilar Flores, Carmen María Martínez, Simón Navarro. Photocatalytic degradation of five sulfonylurea herbicides in aqueous semiconductor suspensions under natural sunlight. Chemosphere. 2012 May; 87(8):954-61. doi: 10.1016/j.chemosphere.2012.01.056. [PMID: 22356857]
  • Richard Engbersen, Rosalinde Masereeuw, Miriam A van Gestel, Helene L M Siero, Miek M Moons, Paul Smits, Frans G M Russel. Differential effects of sulfonylurea derivatives on vascular ATP-sensitive potassium channels. European journal of pharmacology. 2012 Apr; 681(1-3):75-9. doi: 10.1016/j.ejphar.2012.02.006. [PMID: 22366200]
  • Yasmeen Maniyar, Prabhu Bhixavatimath. Antihyperglycemic and hypolipidemic activities of aqueous extract of Carica papaya Linn. leaves in alloxan-induced diabetic rats. Journal of Ayurveda and integrative medicine. 2012 Apr; 3(2):70-4. doi: 10.4103/0975-9476.96519. [PMID: 22707862]
  • Adriana M Hung, Christianne L Roumie, Robert A Greevy, Xulei Liu, Carlos G Grijalva, Harvey J Murff, T Alp Ikizler, Marie R Griffin. Comparative effectiveness of incident oral antidiabetic drugs on kidney function. Kidney international. 2012 Apr; 81(7):698-706. doi: 10.1038/ki.2011.444. [PMID: 22258320]
  • Lisa M Younk, Stephen N Davis. Evaluation of colesevelam hydrochloride for the treatment of type 2 diabetes. Expert opinion on drug metabolism & toxicology. 2012 Apr; 8(4):515-25. doi: 10.1517/17425255.2012.672973. [PMID: 22432790]
  • Xiao-qing Zhang, Zhao-wen Wang, Jun-wei Fan, Yu-ping Li, Zheng Jiao, Jun-wei Gao, Zhi-hai Peng, Gao-lin Liu. The impact of sulfonylureas on tacrolimus apparent clearance revealed by a population pharmacokinetics analysis in Chinese adult liver-transplant patients. Therapeutic drug monitoring. 2012 Apr; 34(2):126-33. doi: 10.1097/ftd.0b013e31824a67eb. [PMID: 22377746]
  • Wijtske Annema, Uwe Jf Tietge. Regulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies. Nutrition & metabolism. 2012 Mar; 9(1):25. doi: 10.1186/1743-7075-9-25. [PMID: 22458435]
  • Fang Wang, Erik M Olson, Show-Ling Shyng. Role of Derlin-1 protein in proteostasis regulation of ATP-sensitive potassium channels. The Journal of biological chemistry. 2012 Mar; 287(13):10482-10493. doi: 10.1074/jbc.m111.312223. [PMID: 22311976]
  • Thomas Karagiannis, Paschalis Paschos, Konstantinos Paletas, David R Matthews, Apostolos Tsapas. Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis. BMJ (Clinical research ed.). 2012 Mar; 344(?):e1369. doi: 10.1136/bmj.e1369. [PMID: 22411919]
  • Petra Kühner, Renate Prager, Damian Stephan, Ulrich Russ, Marcus Winkler, David Ortiz, Joseph Bryan, Ulrich Quast. Importance of the Kir6.2 N-terminus for the interaction of glibenclamide and repaglinide with the pancreatic K(ATP) channel. Naunyn-Schmiedeberg's archives of pharmacology. 2012 Mar; 385(3):299-311. doi: 10.1007/s00210-011-0709-8. [PMID: 22083559]
  • Pan-wei Mu, Yan-ming Chen, Hong-yun Lu, Xing-qiao Wen, Yan-hua Zhang, Ru-ying Xie, Jiong Shu, Man-man Wang, Long-yi Zeng. Effects of a combination of oral anti-diabetes drugs with basal insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes. Diabetes/metabolism research and reviews. 2012 Mar; 28(3):236-40. doi: 10.1002/dmrr.1292. [PMID: 21898754]
  • Vishal Gupta. Pleiotropic effects of incretins. Indian journal of endocrinology and metabolism. 2012 Mar; 16 Suppl 1(?):S47-56. doi: 10.4103/2230-8210.94259. [PMID: 22701844]
  • Toshiyuki Takanohashi, Harumi Arisaka, Kazuyuki Ubukata, Masahiro Hayashi, Yasuhiko Yamada. Comparison of the rapidity of onset of the therapeutic effect between nateglinide and mitiglinide by PK/PD analysis in rats. European journal of drug metabolism and pharmacokinetics. 2012 Mar; 37(1):9-15. doi: 10.1007/s13318-011-0068-3. [PMID: 22012638]
  • Abhay Gundgurthi, Sandeep Kharb, M K Dutta, R Pakhetra, M K Garg. Insulin poisoning with suicidal intent. Indian journal of endocrinology and metabolism. 2012 Mar; 16 Suppl 1(?):S120-2. doi: 10.4103/2230-8210.94254. [PMID: 22701832]
  • Yael Dinur Schejter, Elliot Turvall, Zvi Ackerman. Characteristics of patients with sulphonurea-induced hypoglycemia. Journal of the American Medical Directors Association. 2012 Mar; 13(3):234-8. doi: 10.1016/j.jamda.2010.07.014. [PMID: 21450199]
  • Ajay Chaudhuri, Julio Rosenstock, Andres DiGenio, Luigi Meneghini, Priscilla Hollander, Janet B McGill, Paresh Dandona, John Ilgenfritz, Matthew Riddle. Comparing the effects of insulin glargine and thiazolidinediones on plasma lipids in type 2 diabetes: a patient-level pooled analysis. Diabetes/metabolism research and reviews. 2012 Mar; 28(3):258-67. doi: 10.1002/dmrr.1305. [PMID: 22081557]
  • S Larsen, R Rabøl, C N Hansen, S Madsbad, J W Helge, F Dela. Metformin-treated patients with type 2 diabetes have normal mitochondrial complex I respiration. Diabetologia. 2012 Feb; 55(2):443-9. doi: 10.1007/s00125-011-2340-0. [PMID: 22009334]
  • Holger Rehmann. Epac2: a sulfonylurea receptor?. Biochemical Society transactions. 2012 Feb; 40(1):6-10. doi: 10.1042/bst20110640. [PMID: 22260657]
  • Jeong-Eun Kim, Chong-Hyun Won, Sungeun Chang, Mi-Woo Lee, Jee-Ho Choi, Kee-Chan Moon. Linear lichen planus pigmentosus of the forehead treated by neodymium:yttrium-aluminum-garnet laser and topical tacrolimus. The Journal of dermatology. 2012 Feb; 39(2):189-91. doi: 10.1111/j.1346-8138.2011.01233.x. [PMID: 21951348]
  • T Mizuno, K Ito, Y Miyagawa, K Kimura, Y Suzuki, M Mizuno, Y Ito, Y Funahashi, R Hattori, M Gotoh, Y Noda, K Yamada. Renal impairment after laparoscopic radical nephrectomy affects hypoglycaemic therapy. Journal of clinical pharmacy and therapeutics. 2012 Feb; 37(1):49-52. doi: 10.1111/j.1365-2710.2011.01247.x. [PMID: 21332567]
  • Ying-Chuen Lai, Chou-Shiang Wang, Yi-Ching Wang, Yu-Ling Hsu, Lee-Ming Chuang. Falsely decreased HbA1c in a type 2 diabetic patient treated with dapsone. Journal of the Formosan Medical Association = Taiwan yi zhi. 2012 Feb; 111(2):109-12. doi: 10.1016/j.jfma.2012.01.007. [PMID: 22370290]
  • Hiroaki Yashiro, Yoshiyuki Tsujihata, Koji Takeuchi, Masatoshi Hazama, Paul R V Johnson, Patrik Rorsman. The effects of TAK-875, a selective G protein-coupled receptor 40/free fatty acid 1 agonist, on insulin and glucagon secretion in isolated rat and human islets. The Journal of pharmacology and experimental therapeutics. 2012 Feb; 340(2):483-9. doi: 10.1124/jpet.111.187708. [PMID: 22106100]
  • Kim-Hanh Le Quan Sang, Jean-Baptiste Arnoux, Asmaa Mamoune, Cécile Saint-Martin, Christine Bellanné-Chantelot, Vassili Valayannopoulos, Anais Brassier, Honorine Kayirangwa, Valérie Barbier, Christine Broissand, Jean-Roch Fabreguettes, Brigitte Charron, Jean-Christophe Thalabard, Pascale de Lonlay. Successful treatment of congenital hyperinsulinism with long-acting release octreotide. European journal of endocrinology. 2012 Feb; 166(2):333-9. doi: 10.1530/eje-11-0874. [PMID: 22048969]
  • C Beysen, E J Murphy, K Deines, M Chan, E Tsang, A Glass, S M Turner, J Protasio, T Riiff, M K Hellerstein. Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study. Diabetologia. 2012 Feb; 55(2):432-42. doi: 10.1007/s00125-011-2382-3. [PMID: 22134839]
  • Michael E Cobble, Robert Frederich. Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data. Cardiovascular diabetology. 2012 Jan; 11(?):6. doi: 10.1186/1475-2840-11-6. [PMID: 22248301]
  • Tina Vilsbøll, Mikkel Christensen, Anders E Junker, Filip K Knop, Lise Lotte Gluud. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials. BMJ (Clinical research ed.). 2012 Jan; 344(?):d7771. doi: 10.1136/bmj.d7771. [PMID: 22236411]
  • Jothydev Kesavadev, Arun Shankar, Gopika Krishnan, Sunitha Jothydev. Liraglutide therapy beyond glycemic control: an observational study in Indian patients with type 2 diabetes in real world setting. International journal of general medicine. 2012; 5(?):317-22. doi: 10.2147/ijgm.s27886. [PMID: 22536087]
  • Hyo Won Jung, Jin Ki Jung, Mahesh Ramalingam, Cheol-Ho Yoon, Hyo Sang Bae, Yong-Ki Park. Anti-diabetic effect of Wen-pi-tang-Hab-Wu-ling-san extract in streptozotocin-induced diabetic rats. Indian journal of pharmacology. 2012 Jan; 44(1):97-102. doi: 10.4103/0253-7613.91877. [PMID: 22345879]
  • Edward C Chao. Dapagliflozin: an evidence-based review of its potential in the treatment of type-2 diabetes. Core evidence. 2012; 7(?):21-8. doi: 10.2147/ce.s16359. [PMID: 22701099]
  • Michael James Zema. Colesevelam hydrochloride: evidence for its use in the treatment of hypercholesterolemia and type 2 diabetes mellitus with insights into mechanism of action. Core evidence. 2012; 7(?):61-75. doi: 10.2147/ce.s26725. [PMID: 22936894]
  • R R Henry, V R Aroda, S Mudaliar, W T Garvey, H S Chou, M R Jones. Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus. Diabetes, obesity & metabolism. 2012 Jan; 14(1):40-6. doi: 10.1111/j.1463-1326.2011.01486.x. [PMID: 21831167]
  • Yoshimasa Aso, Noriyuki Ozeki, Tomoko Terasawa, Rika Naruse, Kenji Hara, Mariko Suetsugu, Kohzo Takebayashi, Mitsuei Shibazaki, Kohsuke Haruki, Kimio Morita, Toshihiko Inukai. Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea. Translational research : the journal of laboratory and clinical medicine. 2012 Jan; 159(1):25-31. doi: 10.1016/j.trsl.2011.09.005. [PMID: 22153807]
  • Kenji Hara, Kyoko Omori, Yumiko Sumioka, Yoshimasa Aso. Spontaneous platelet aggregation evaluated by laser light scatter in patients with type 2 diabetes: effects of short-term improved glycemic control and adiponectin. Translational research : the journal of laboratory and clinical medicine. 2012 Jan; 159(1):15-24. doi: 10.1016/j.trsl.2011.07.007. [PMID: 22153806]
  • Nalinee Poolsup, Naeti Suksomboon, Wanwaree Setwiwattanakul. Efficacy of various antidiabetic agents as add-on treatments to metformin in type 2 diabetes mellitus: systematic review and meta-analysis. ISRN endocrinology. 2012; 2012(?):798146. doi: 10.5402/2012/798146. [PMID: 22619731]
  • Maria Pietrzak-Nowacka, Krzysztof Safranow, Agnieszka Bińczak-Kuleta, Jacek Rózański, Kazimierz Ciechanowski, Andrzej Ciechanowicz. Association of C49620T ABCC8 polymorphism with anthropometric and metabolic parameters in patients with autosomal dominant polycystic kidney disease: a preliminary study. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 2012; 32(2):153-9. doi: 10.3265/nefrologia.pre2011.dec.10663. [PMID: 22466262]
  • Najah R Hadi, Fadhil Al-Amran, Mohammad A A Hussein, Fadhil A Rezeg. Evaluation of the effects of glimepiride (Amaryl) and repaglinide (novoNorm) on atherosclerosis progression in high cholesterol-fed male rabbits. Journal of cardiovascular disease research. 2012 Jan; 3(1):5-11. doi: 10.4103/0975-3583.91592. [PMID: 22346138]
  • Naziha Bakouh, Baya Chérif-Zahar, Philippe Hulin, Dominique Prié, Gérard Friedlander, Aleksander Edelman, Gabrielle Planelles. Functional interaction between CFTR and the sodium-phosphate co-transport type 2a in Xenopus laevis oocytes. PloS one. 2012; 7(4):e34879. doi: 10.1371/journal.pone.0034879. [PMID: 22514683]
  • Man-Wo Tsang. The management of type 2 diabetic patients with hypoglycaemic agents. ISRN endocrinology. 2012; 2012(?):478120. doi: 10.5402/2012/478120. [PMID: 22645689]
  • Anne Zanchi, Roger Lehmann, Jacques Philippe. Antidiabetic drugs and kidney disease--recommendations of the Swiss Society for Endocrinology and Diabetology. Swiss medical weekly. 2012; 142(?):w13629. doi: 10.4414/smw.2012.13629. [PMID: 22987488]
  • Majambu Mbikay. Therapeutic Potential of Moringa oleifera Leaves in Chronic Hyperglycemia and Dyslipidemia: A Review. Frontiers in pharmacology. 2012; 3(?):24. doi: 10.3389/fphar.2012.00024. [PMID: 22403543]
  • H-J Kim, K-H Yoon, M-J Kang, H-W Yim, K-S Lee, V Vuksan, M-K Sung. A six-month supplementation of mulberry, korean red ginseng, and banaba decreases biomarkers of systemic low-grade inflammation in subjects with impaired glucose tolerance and type 2 diabetes. Evidence-based complementary and alternative medicine : eCAM. 2012; 2012(?):735191. doi: 10.1155/2012/735191. [PMID: 22474520]
  • V T T Huyen, D V Phan, P Thang, P T Ky, N K Hoa, C G Ostenson. Antidiabetic Effects of Add-On Gynostemma pentaphyllum Extract Therapy with Sulfonylureas in Type 2 Diabetic Patients. Evidence-based complementary and alternative medicine : eCAM. 2012; 2012(?):452313. doi: 10.1155/2012/452313. [PMID: 23125867]
  • M L Kundlik, B H Zaware, S R Kuchekar. Rapid and specific approach for direct measurement of glimepiride in human plasma by LC-ESI-MS-MS employing automated 96 well format: application to a bioequivalence study. Journal of chromatographic science. 2012 Jan; 50(1):64-70. doi: 10.1093/chromsci/bmr005. [PMID: 22291058]
  • S Gurudeeban, K Satyavani, T Ramanathan, T Balasubramanian. Antidiabetic effect of a black mangrove species Aegiceras corniculatum in alloxan-induced diabetic rats. Journal of advanced pharmaceutical technology & research. 2012 Jan; 3(1):52-6. doi: 10.4103/2231-4040.93560. [PMID: 22470894]
  • Susan Sam, Steven Haffner, Michael H Davidson, Ralph D'Agostino, Alfonso Perez, Theodore Mazzone. Pioglitazone-mediated changes in lipoprotein particle composition are predicted by changes in adiponectin level in type 2 diabetes. The Journal of clinical endocrinology and metabolism. 2012 Jan; 97(1):E110-4. doi: 10.1210/jc.2011-1699. [PMID: 22072742]
  • Shinya Furukawa, Teru Kumagi, Teruki Miyake, Teruhisa Ueda, Tetsuji Niiya, Keiichiro Nishino, Shigeto Murakami, Masato Murakami, Bunzo Matsuura, Morikazu Onji. Suicide attempt by an overdose of sitagliptin, an oral hypoglycemic agent: a case report and a review of the literature. Endocrine journal. 2012; 59(4):329-33. doi: 10.1507/endocrj.ej11-0390. [PMID: 22277726]
  • O N Goncharenko, A S Ametov, M R Isakova. [Evaluation of the efficiency and safety of therapy with a combination of sulfonylurea derivatives and insulin sensitizers for type 2 diabetes mellitus]. Terapevticheskii arkhiv. 2012; 84(8):67-71. doi: ". [PMID: 22994093]
  • Mohamed M Hefnawy, Maha A Sultan, Haya I Al-Johar, Mohamed G Kassem, Hassan Y Aboul-Enein. Multi-objective optimization strategy based on desirability functions used for electrophoratic separation and quantification of rosiglitazone and glimepiride in plasma and formulations. Drug testing and analysis. 2012 Jan; 4(1):39-47. doi: 10.1002/dta.260. [PMID: 21416633]
  • U Deniz Dincer. Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?. Diabetes, metabolic syndrome and obesity : targets and therapy. 2012; 5(?):89-99. doi: 10.2147/dmso.s30005. [PMID: 22563249]
  • Katalin Kiss, Anna Brozik, Nora Kucsma, Alexandra Toth, Melinda Gera, Laurence Berry, Alice Vallentin, Henri Vial, Michel Vidal, Gergely Szakacs. Shifting the paradigm: the putative mitochondrial protein ABCB6 resides in the lysosomes of cells and in the plasma membrane of erythrocytes. PloS one. 2012; 7(5):e37378. doi: 10.1371/journal.pone.0037378. [PMID: 22655043]
  • Jürgen E Müller, Dagmar Sträter-Müller, Hans-Joachim Marks, Michael Gläsner, Philipp Kneppe, Beate Clemens-Harmening, Harald Menker. Carbohydrate restricted diet in conjunction with metformin and liraglutide is an effective treatment in patients with deteriorated type 2 diabetes mellitus: Proof-of-concept study. Nutrition & metabolism. 2011 Dec; 8(1):92. doi: 10.1186/1743-7075-8-92. [PMID: 22196251]
  • Esayas K Gudina, Solomon T Amade, Fessahaye A Tesfamichael, Rana Ram. Assessment of quality of care given to diabetic patients at Jimma University Specialized Hospital diabetes follow-up clinic, Jimma, Ethiopia. BMC endocrine disorders. 2011 Dec; 11(?):19. doi: 10.1186/1472-6823-11-19. [PMID: 22185229]
  • Marina Franceschetti, Emilio Bueno, Richard A Wilson, Sara L Tucker, Concepción Gómez-Mena, Grant Calder, Ane Sesma. Fungal virulence and development is regulated by alternative pre-mRNA 3'end processing in Magnaporthe oryzae. PLoS pathogens. 2011 Dec; 7(12):e1002441. doi: 10.1371/journal.ppat.1002441. [PMID: 22194688]
  • Kyeumhan Noh, Eunyoung Kim, Taecheon Jeong, MinKyun Na, Moon-Chang Baek, Kwang-Hyeon Liu, Pil-Hoon Park, Beom Soo Shin, Wonku Kang. Simultaneous determination of glimepiride and its metabolites in human plasma by liquid chromatography coupled to a tandem mass spectrometry. Archives of pharmacal research. 2011 Dec; 34(12):2073-8. doi: 10.1007/s12272-011-1210-0. [PMID: 22210033]
  • Georg Biesenbach, Gert Bodlaj, Stephan Ebner, Peter Biesenbach, Herwig Pieringer. Metabolic control and vascular diseases under oral antidiabetic drug versus insulin therapy and/or diet alone during the first year of hemodialysis in type 2 diabetic patients with ESRD. International urology and nephrology. 2011 Dec; 43(4):1155-60. doi: 10.1007/s11255-010-9804-x. [PMID: 20640938]
  • Kwang-Hee Shin, Sung Eun Kim, Seo Hyun Yoon, Joo-Youn Cho, In-Jin Jang, Sang-Goo Shin, Kyung-Sang Yu. Pharmacokinetic comparison of a new sustained-release formulation of glimepiride/metformin 1/500 mg combination tablet and a sustained-release formulation of glimepiride/metformin 2/500 mg combination tablet in healthy Korean male volunteers: a randomized, 2-sequence, 2-period, 2-treatment crossover study. Clinical therapeutics. 2011 Nov; 33(11):1809-18. doi: 10.1016/j.clinthera.2011.10.003. [PMID: 22036245]
  • D R Owens, R Swallow, K A Dugi, H J Woerle. Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study. Diabetic medicine : a journal of the British Diabetic Association. 2011 Nov; 28(11):1352-61. doi: 10.1111/j.1464-5491.2011.03387.x. [PMID: 21781152]
  • Ryan Matsuda, Jeanethe Anguizola, K S Joseph, David S Hage. High-performance affinity chromatography and the analysis of drug interactions with modified proteins: binding of gliclazide with glycated human serum albumin. Analytical and bioanalytical chemistry. 2011 Nov; 401(9):2811-9. doi: 10.1007/s00216-011-5382-8. [PMID: 21922305]
  • Y Wang, L Li, M Yang, H Liu, G Boden, G Yang. Glucagon-like peptide-1 receptor agonists versus insulin in inadequately controlled patients with type 2 diabetes mellitus: a meta-analysis of clinical trials. Diabetes, obesity & metabolism. 2011 Nov; 13(11):972-81. doi: 10.1111/j.1463-1326.2011.01436.x. [PMID: 21651690]
  • Saleh N Mwafy, Maged M Yassin. Antidiabetic activity evaluation of glimepiride and Nerium oleander extract on insulin, glucose levels and some liver enzymes activities in experimental diabetic rat model. Pakistan journal of biological sciences : PJBS. 2011 Nov; 14(21):984-90. doi: 10.3923/pjbs.2011.984.990. [PMID: 22514888]
  • David Sullivan, Peta Forder, John Simes, Malcolm Whiting, Leonard Kritharides, Alistair Merrifield, Mark Donoghoe, Peter G Colman, Neil Graham, Hannu Haapamäki, Anthony Keech. Associations between the use of metformin, sulphonylureas, or diet alone and cardiovascular outcomes in 6005 people with type 2 diabetes in the FIELD study. Diabetes research and clinical practice. 2011 Nov; 94(2):284-90. doi: 10.1016/j.diabres.2011.07.028. [PMID: 21862166]
  • Y-H Lee, B-W Lee, S W Chun, B S Cha, H C Lee. Predictive characteristics of patients achieving glycaemic control with insulin after sulfonylurea failure. International journal of clinical practice. 2011 Oct; 65(10):1076-84. doi: 10.1111/j.1742-1241.2011.02755.x. [PMID: 21923847]
  • R R Kapoor, S E Flanagan, C T James, J McKiernan, A M Thomas, S C Harmer, J P Shield, A Tinker, S Ellard, K Hussain. Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations. Diabetologia. 2011 Oct; 54(10):2575-83. doi: 10.1007/s00125-011-2207-4. [PMID: 21674179]
  • K Strojek, K H Yoon, V Hruba, M Elze, A M Langkilde, S Parikh. Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial. Diabetes, obesity & metabolism. 2011 Oct; 13(10):928-38. doi: 10.1111/j.1463-1326.2011.01434.x. [PMID: 21672123]
  • Zhao-hui Lü, Chang-yu Pan, Yan Gao, Li-xin Guo, Guang Ning, Zhi-min Liu, Ju-ming Lu, Pei-hong Jia, Xiao-xia Wang, Shou-Yue Sun, Jiao-Yang Zheng. [A randomized, double blind, placebo-controlled, parallel and multicenter study to evaluate the safety and efficacy of pioglitazone with sulphonylurea in type 2 diabetic patients]. Zhonghua nei ke za zhi. 2011 Oct; 50(10):826-30. doi: NULL. [PMID: 22321321]
  • E L Lim, K G Hollingsworth, B S Aribisala, M J Chen, J C Mathers, R Taylor. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011 Oct; 54(10):2506-14. doi: 10.1007/s00125-011-2204-7. [PMID: 21656330]
  • Minori Mizoguchi, Nobuhiro Tahara, Atsuko Tahara, Yoshikazu Nitta, Norihiro Kodama, Toyoharu Oba, Kazutoshi Mawatari, Hideo Yasukawa, Hayato Kaida, Masatoshi Ishibashi, Naofumi Hayabuchi, Haruhito Harada, Hisao Ikeda, Sho-Ichi Yamagishi, Tsutomu Imaizumi. Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta. JACC. Cardiovascular imaging. 2011 Oct; 4(10):1110-8. doi: 10.1016/j.jcmg.2011.08.007. [PMID: 21999871]
  • A Chaudhuri, P Dandona. Effects of insulin and other antihyperglycaemic agents on lipid profiles of patients with diabetes. Diabetes, obesity & metabolism. 2011 Oct; 13(10):869-79. doi: 10.1111/j.1463-1326.2011.01423.x. [PMID: 21569185]
  • Ji Sung Yoon, Hyoung Woo Lee. Understanding the cardiovascular effects of incretin. Diabetes & metabolism journal. 2011 Oct; 35(5):437-43. doi: 10.4093/dmj.2011.35.5.437. [PMID: 22111033]
  • Hyun Jeong Jeon, Tae Keun Oh. Comparison of vildagliptin-metformin and glimepiride-metformin treatments in type 2 diabetic patients. Diabetes & metabolism journal. 2011 Oct; 35(5):529-35. doi: 10.4093/dmj.2011.35.5.529. [PMID: 22111045]
  • Hyun-Jung Cho, Soo-Youn Lee, Youn-Gyoon Kim, Soo-Yeon Oh, Jong-Won Kim, Wooseong Huh, Woo-Seong Huh, Jae-Wook Ko, Hyung-Gun Kim. Effect of genetic polymorphisms on the pharmacokinetics and efficacy of glimepiride in a Korean population. Clinica chimica acta; international journal of clinical chemistry. 2011 Sep; 412(19-20):1831-4. doi: 10.1016/j.cca.2011.06.014. [PMID: 21704609]
  • Cathrin E Bruederle, Joel Gay, Show-Ling Shyng. A role of the sulfonylurea receptor 1 in endocytic trafficking of ATP-sensitive potassium channels. Traffic (Copenhagen, Denmark). 2011 Sep; 12(9):1242-56. doi: 10.1111/j.1600-0854.2011.01227.x. [PMID: 21649805]
  • D S H Bell, M Dharmalingam, S Kumar, R B Sawakhande. Triple oral fixed-dose diabetes polypill versus insulin plus metformin efficacy demonstration study in the treatment of advanced type 2 diabetes (TrIED study-II). Diabetes, obesity & metabolism. 2011 Sep; 13(9):800-5. doi: 10.1111/j.1463-1326.2011.01408.x. [PMID: 21477065]
  • Giuseppe Derosa, Pietro Putignano, Antonio C Bossi, Aldo Bonaventura, Fabrizio Querci, Ivano G Franzetti, Barbara Guazzini, Gianpaolo Testori, Elena Fogari, Pamela Maffioli. Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients. European journal of pharmacology. 2011 Sep; 666(1-3):251-6. doi: 10.1016/j.ejphar.2011.05.051. [PMID: 21645507]
  • Xiao-lin Tong, Jun Song, Lin-hua Zhao, Hang-yu Ji. Kaiyuqingre formula improves insulin secretion via regulating uncoupling protein-2 and KATP channel. Chinese medical journal. 2011 Sep; 124(17):2746-50. doi: NULL. [PMID: 22040435]